Science Explorer Back to mapMap
Discussion
Researcher · Meir Medical Center · Israel

Daniel Keizman

Daniel Keizman publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Prostate Cancer Treatment and Research, Renal cell carcinoma treatment and Radiopharmaceutical Chemistry and Applications.

ORCID 0000-0002-1087-1147 OpenAlex
World rank
#809,800
of 7,710,434 ranked researchers
Rank in Israel
#5,825
of 38,292
Works
176
Citations
2.7k
Citations per work
15.5
h-index
27
i10-index 47Top 11% in Pulmonary and Respiratory Medicine
Daniel Keizman

What does Daniel Keizman research?

Daniel Keizman's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 117 works · 66.6% of their workMedicine: 117 works · 66.6% of their workPulmonary and Respiratory Medicine: 65 works · 36.7% of their workOncology: 23 works · 13.3% of their workRadiology, Nuclear Medicine and Imaging: 20 works · 11.6% of their workSurgery: 9 works · 5.0% of their workEverything else: 32 works · 18.4% of their workLife Sciences: 26 works · 15.0% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 15.0% of their workCancer Research: 17 works · 9.4% of their workMolecular Biology: 10 works · 5.6% of their workTHEIR WORKDaniel Keizman176works
Life Sciences15%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11766.6%
  2. Everything else3218.4%
    1. Biochemistry, Genetics and Molecular Biology2615.0%
  1. 1Pulmonary and Respiratory Medicine37% of their works
  2. 2Oncology13% of their works
  3. 3Radiology, Nuclear Medicine and Imaging12% of their works
  4. 4Cancer Research9% of their works
  5. 5Molecular Biology6% of their works
  6. 6Surgery5% of their works

Research topics

Which keywords describe Daniel Keizman's research?

The keywords of their largest research topics: Genetic Mutations, Immunotherapy, Prostate Cancer, Androgen Receptor, Genomic Profiling, Clinical Guidelines, Targeted Therapy and Metastatic.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Genetic Mutations1242 topics
  2. Immunotherapy1242 topics
  3. Prostate Cancer1082 topics
  4. Androgen Receptor811 topic
  5. Genomic Profiling811 topic
  6. Clinical Guidelines702 topics
  7. Targeted Therapy612 topics
  8. Metastatic431 topic
  9. Renal Cell Carcinoma431 topic
  10. PET Imaging401 topic
  11. Radiopharmaceuticals401 topic
  12. Cancer362 topics
  13. Radiation Therapy271 topic
  14. Screening271 topic
  15. Cancer Genomics211 topic
  16. Fatty Acid Synthase211 topic
  17. Immune Checkpoint Blockade211 topic
  18. Lipid Metabolism211 topic
  19. Mutational Signatures211 topic
  20. PD-1 and PD-L1211 topic
  21. Imaging151 topic
  22. PET/CT151 topic

Where does Daniel Keizman work?

Daniel Keizman's main affiliation in the publication record is Meir Medical Center, Israel.

How many publications and citations does Daniel Keizman have?

OpenAlex counts 176 works and 2,724 citations for Daniel Keizman, an h-index of 27, ranking #809,800 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Daniel Keizman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.